June 21, 2018
Former Receptos CEO Faheem Hasnain, pictured in this 2015 file photo, has grown several biotech companies that were acquired by industry giants. Hasnain, now the CEO of Gossamer Bio, said employee continuity is a key factor in smooth biotech acquisitions.
Stories this photo appears in:
Mergers: Pharma Must Consider Many Factors in Buy
Earlier this month, an executive from New Jersey-based Celgene blamed Receptos, a San Diego firm that it bought, for a major regulatory setback.